Changes in Gene Transcription and Immunophenotypes Following Mepolizumab Treatment for Asthma

Clinical trial NCT05002621 · COMPLETED

Trial details

NCT number: NCT05002621
Sponsor: Mayo Clinic
Status: COMPLETED
Study type: OBSERVATIONAL

Eosinophilic Asthma

Start date: 2021-02-16
Primary completion: 2023-02-13
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.